FDA approves Lilly’s Zepbound for obstructive sleep apnea
Lilly’s stock was up slightly in after-hours trading.
Health Care & Life Sciences
-
Q&A: OrthoIndy’s John Ryan talks about staying independent in a consolidating health care industry
The economics are daunting: Rising costs and flat reimbursements mean private groups must work harder to stay independent.
Read More -
Why Lilly is pouring billions into LEAP
In recent years, the pharmaceutical manufacturer has seen dizzying growth in its pipeline for a wide range of diseases. And modes of drug delivery are becoming increasingly complex.
Read More -
Blood specialists in demand as caseloads grow
In response, an Indianapolis medical practice is trying to train more early-career physicians in the field of hematology to reverse the trend of dwindling numbers of physicians entering the field.
Read More -
IEDC still looking for buyers for portion of GM stamping plant property
Economic development leaders want the 45 acres to be developed as the OneHealth Innovation District—a partnership between Elanco Animal Health, Purdue University and the Indiana Economic Development Corp.
Read More
Articles
Lilly stock caught up in wave of uncertainty
After a stunning 703% run-up in price over the past five years, shares of Eli Lilly and Co. have been on a roller-coaster ride since September.
GeniPhys builds momentum with wound care technology
After 10 long years, the company that has developed a collagen biomaterial to help heal tissue is readying itself for its next big steps: regulatory approval and commercial launch.
Lilly CEO Dave Ricks named Watanabe Award winner
Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care innovation.
Years after fanfare, hospital remains unbuilt
But two years after the groundbreaking for an Ascension St. Vincent facility in West Lafayette, the planned $25 million development has little to show for itself. The 7-acre site sits empty, with no indication that anything is coming soon.
Insurer-provider contract impasses leave many patients without care
Indiana physicians are keeping an eye on the trend of large insurers dropping medical practices from their networks, which they call a classic case of David versus Goliath.
Carmel-based MBX Biosciences shares jump 48% in Nasdaq debut
The five-year-old company is developing treatments for endocrine and metabolic disorders, such as hypoparathyroidism, post-bariatric hypoglycemia and obesity. Its positive reception on Wall Street was seen as an extension of the general enthusiasm for obesity treatments.
Lilly names new chief financial officer
Lucas Montarce, who has been with Lilly since 2001 and most recently served as president for its Spain, Portugal and Greece operations, is now the company’s CFO and executive vice president.
Fishers-based Flexware acquires North Carolina-based engineering services firm
Fishers-based Flexware Integration LLC, a fast-growing IT services provider, has acquired Castle Hill Technologies LLC, a North Carolina-based company that provides engineering services to the pharmaceutical industry.
Medical debt proposal draws mixed response
A national proposal to remove medical debt from consumer credit reports could have a significant impact in Indiana, where the percentage of residents with delinquent medical debt is higher than in 39 other states.
Proposed Medicare cuts put squeeze on doctors
Last month, the federal Medicare program proposed a 2.9% cut to physician pay for 2025. That marked the fifth straight year that regulators proposed cutting payments to doctors for thousands of services, from stitching a wound to replacing a knee.
Lilly inches toward rare $1 trillion market-value distinction
The spotlight is turning to Indianapolis-based Eli Lilly and Co. as the next possible member of the so-called “Trillion-Dollar Club,” based on the drugmaker’s climbing stock price and swelling demand for its treatments for diabetes, obesity and other diseases.
IU Health’s massive hospital project is on schedule, should ‘top out’ next spring
Work on Indiana University Health’s $4.3 billion downtown hospital campus, one of the most expensive construction projects in Indiana history, is set to be finished in late 2027.
Zimmer Biomet CEO says company can’t make long-term commitment to Warsaw if U.S. 30 isn’t upgraded
Ivan Tornos’ comments came during the U.S. 30 Summit in Warsaw, an event designed to discuss the safety and economic implications of not modernizing the 155-mile stretch of U.S. 30 between Fort Wayne and Valparaiso.
Pharmacy software company lays off 71, including 11 at Indy HQ
Just three years ago, Indianapolis-based Innovation Associates had huge hopes for growth here. But instead of growing, the company is now shrinking. Last week, the company quietly laid off 11 people in the Indy office and 60 people in other markets.
OneHealth designation could drive innovation in Elanco/Purdue space
State and corporate leaders believe a tech park taking shape on the western edge of downtown could be a launchpad for health sciences innovation and commercialization as part of the state’s ambitious economic development portfolio.
Elanco completes $1.3B sale of aqua business, allowing it to reduce debt load
The company had debt of $5.7 billion as of March 31 and has been under pressure from Wall Street to reduce it.
Lilly to buy Massachusetts biopharma company for $3.2B
Massachusetts-based Morphic Holding Inc. is a nine-year old, publicly traded company that is developing a class of drugs known as oral integrin therapies to treat autoimmune diseases, pulmonary hypertensive diseases, fibrotic diseases and cancer.
The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma
The decision also could affect other major bankruptcies, including the $2.4 billion bankruptcy plan for the Boy Scouts of America that has been approved by a federal judge, lawyers said.
Franciscan Alliance sued by Indy physician for breach of contract, interfering in practice
Dr. Greg Hardin, an orthopedic surgeon who specializes in sports medicine, claims that Franciscan Alliance engaged in conduct harmful to his practice over the course of several years.